SG Market: Spore shares may see a positive opening after Wall Street's firmer close on Tue but gains are not expected to be strong amid conflicting headlines coming out of Europe and lingering uncertainty over what EU leaders will pull out of the hat to tackle the debt crisis. With US stock index futures again in the red, the STI is unlikelt to test Mon's high of 2789 with 50 DMA at 2752 being the 1st line of resistance. Support lies at 2720, followed by 2600.
Stocks making the news include CapitaMalls Asia which reported a 30.3% drop in 3Q net profit; Sembcorp Marine after its SMOE unit secures a US$100m LNG module assembly contract in Australia; and China Animal Healthcare, which is considering a potential delisting from SGX (while keeping its primary HK listing).
No comments:
Post a Comment